Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer
Open Access
- 16 September 2015
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 7 (1) , 100
Abstract
A number of clinico-pathological criteria and molecular profiles have been used to stratify patients into high- and low-risk groups. Currently, there are still no effective methods to determine which patients harbor micrometastatic disease after standard breast cancer therapy and who will eventually develop local or distant recurrence. The purpose of our study was to identify circulating DNA methylation changes that can be used for prediction of metastatic breast cancer (MBC). Differential methylation analysis revealed ~5.0 × 106 differentially methylated CpG loci in MBC compared with healthy individuals (H) or disease-free survivors (DFS). In contrast, there was a strong degree of similarity between H and DFS. Overall, MBC demonstrated global hypomethylation and focal CpG island (CPGI) hypermethylation. Data analysis identified 21 novel hotspots, within CpG islands, that differed most dramatically in MBC compared with H or DFS. This unbiased analysis of cell-free (cf) DNA identified 21 DNA hypermethylation hotspots associated with MBC and demonstrated the ability to distinguish tumor-specific changes from normal-derived signals at the whole-genome level. This signature is a potential blood-based biomarker that could be advantageous at the time of surgery and/or after the completion of chemotherapy to indicate patients with micrometastatic disease who are at a high risk of recurrence and who could benefit from additional therapy.Keywords
This publication has 28 references indexed in Scilit:
- Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast CancerCancer Research, 2014
- Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingProceedings of the National Academy of Sciences, 2013
- A Perspective on Cancer Cell MetastasisScience, 2011
- Signaling pathways in breast cancer metastasis - novel insights from functional genomicsBreast Cancer Research, 2011
- Methylation profile of circulating plasma DNA in patients with pancreatic cancerJournal of Surgical Oncology, 2008
- CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate CancerJournal of Urology, 2008
- Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNAGenome Research, 2007
- A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.2007
- Breast cancer metastasis: markers and modelsNature Reviews Cancer, 2005
- DNA methylation in serum of breast cancer patients: an independent prognostic marker.2003